You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

2-year disease-free survival rate

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Constipation, Surgical Treatment Trial in Shanghai (Subtotal colectomy was performed)

Completed
  • Constipation
  • Surgical Treatment
  • Subtotal colectomy was performed
  • Shanghai, Shanghai, China
    Shanghai Tenth People's Hospital
Aug 8, 2023

Advanced or Metastatic Paraganglioma/ Pheochromocytoma Trial in Nanjing (Anlotinib)

Recruiting
  • Advanced or Metastatic Paraganglioma/ Pheochromocytoma
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital of Nanjing Medical Univerity
Nov 17, 2021

PLAN-A Data- Bio- and Plan- Bank Collection for SCCA in Denmark

Recruiting
  • Anal Cancer
    • Aarhus, Denmark
    • +2 more
    Oct 5, 2022

    Chronic Hepatitis b, Anti-PD-1 Antibody, Peg-IFNa Trial in Chongqing (Anti-PD-1 antibody, NAs, Peg-IFNa)

    Not yet recruiting
    • Chronic Hepatitis b
    • +2 more
    • Anti-PD-1 antibody
    • +2 more
    • Chongqing, Chongqing, China
      The 2nd affiliated Hospital of Chongqing Medical University
    Mar 14, 2023

    Relapsed Advanced Lymphomas Trial in India (AUR108)

    Not yet recruiting
    • Relapsed Advanced Lymphomas
    • Visakhapatnam, Andhra Pradesh, India
    • +8 more
    Aug 9, 2023

    Breast Cancer Trial in France (Estramustine, Tamoxifen)

    Completed
    • Breast Cancer
    • Avignon, France
    • +20 more
    Mar 6, 2020

    Untreated Childhood Medulloblastoma Trial in Worldwide (drug, radiation, other)

    Active, not recruiting
    Has Results
    • Untreated Childhood Medulloblastoma
    • Birmingham, Alabama
    • +177 more
    Feb 25, 2022

    Mental Health During Whole Life Cycle of Community Schizophrenia

    Recruiting
    • Schizophrenia
      • Shanghai, China
        Shanghai Mental Health Center
      Feb 22, 2022

      Gastric Cancer Stage IV Trial in Wuhan (Toripalimab, Docetaxel, nab-paclitaxel)

      Recruiting
      • Gastric Cancer Stage IV
      • Wuhan, Hubei, China
        Cancer Center, Union Hospital, Tongji Medical College, Huazhong
      Mar 14, 2021

      Gastric Cancer, Esophageal Cancer Trial (FerroTrace® and FerroMag Sentinel Lymph Node Mapping (SLNM) System)

      Not yet recruiting
      • Gastric Cancer
      • Esophageal Cancer
      • FerroTrace® and FerroMag Sentinel Lymph Node Mapping (SLNM) System
      • (no location specified)
      Jun 2, 2023

      Gastric Cancer Trial (Disitamab Vedotin combined with Sintilimab)

      Not yet recruiting
      • Gastric Cancer
      • Disitamab Vedotin combined with Sintilimab
      • (no location specified)
      Jul 2, 2023

      Chronic Hepatitis b, Anti-PD-1 Antibody Trial in Chongqing (Anti-PD-1 antibody, NAs)

      Not yet recruiting
      • Chronic Hepatitis b
      • Anti-PD-1 Antibody
      • Anti-PD-1 antibody
      • NAs
      • Chongqing, Chongqing, China
        The 2nd affiliated Hospital of Chongqing Medical University
      Mar 3, 2023

      Colon Cancer Stage I Trial in Taoyuan (Magicell-NK contains NK cells suspended in 100 mL normal saline)

      Recruiting
      • Colon Cancer Stage I
      • Magicell-NK contains NK cells suspended in 100 mL normal saline
      • Taoyuan, Taiwan
        Chang Gung Memorial Hospital, Linkou
      Sep 28, 2022

      Rate of Pseudoxanthoma Elasticum-associated Choroidal and

      Recruiting
      • Pseudoxanthoma Elasticum
      • No intervention
      • Basel, Basel-Stadt, Switzerland
        University Hospital Basel
      Dec 21, 2022

      Chronic Lymphocytic Leukemia Trial in Salt Lake City (Nicotinamide, Placebo)

      Recruiting
      • Chronic Lymphocytic Leukemia
      • Salt Lake City, Utah
        Huntsman Cancer Institute at University of Utah
      Jan 17, 2023

      Bladder Cancer Trial in United States (Cabozantinib, Atezolizumab, Cystectomy)

      Recruiting
      • Bladder Cancer
      • Hackensack, New Jersey
      • +4 more
      Aug 26, 2022

      Analysis of Circulating Exosomes in Melanoma Patients

      Active, not recruiting
      • Melanoma
        • Besançon, France
          CHU de Besançon
        Feb 23, 2023

        B Cell Lymphomas Trial in Durham (Nivolumab, Microtransplantation)

        Withdrawn
        • B Cell Lymphomas
        • Durham, North Carolina
          Duke University
        Mar 19, 2021

        Glioblastoma Multiforme Trial in United States (TPI 287, Bevacizumab)

        Suspended
        • Glioblastoma Multiforme
        • Birmingham, Alabama
        • +8 more
        Jul 19, 2022

        Breast Cancer, Triple Negative Breast Cancer Trial (Antivascular therapy, Chemotherapy)

        Not yet recruiting
        • Breast Cancer
        • Triple Negative Breast Cancer
        • (no location specified)
        Jun 11, 2023

        Non Small Cell Lung Cancer, Stage III NSCLC, EGFR Activating Mutation Trial in Hangzhou (Almonertinib)

        Recruiting
        • Non Small Cell Lung Cancer
        • +2 more
        • Hangzhou, Zhejiang, China
          Hangzhou Cancer hospital
        Jan 8, 2021

        /Effectiveness of Nivolumab in Routine Oncology Practice

        Active, not recruiting
        • Melanoma
        • Lung Cancer
          • Princeton, New Jersey
            Inventiv
          Feb 24, 2022

          Acute Respiratory Distress Syndrome (ARDS) Trial in Milan, Potenza (Pirfenidone, Placebo)

          Recruiting
          • Acute Respiratory Distress Syndrome (ARDS)
          • Milan, MI, Italy
          • +1 more
          Dec 23, 2022

          Endometrial Cancer Using Plasma Cell-free DNA Fragmentomics

          Recruiting
          • Endometrial Cancer
          • low-depth whole-genome sequencing technology
          • Guangzhou, Guangdong, China
            The Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
          Oct 9, 2023

          NSCLC, Small Cell Lung Cancer, Pancreas Cancer Trial in Shanghai (Infusion of iNKT cells and CD8+T cells)

          Active, not recruiting
          • Non-small Cell Lung Cancer
          • +5 more
          • Infusion of iNKT cells and CD8+T cells
          • Shanghai, Shanghai, China
            Shanghai Public Health Clinical Center
          May 6, 2022